In 2018, the global ophthalmic lasers market was valued at USD 479.0 million and is projected to reach USD 989.9 million by 2032, reflecting a compound annual growth rate (CAGR) of 5.3% over the forecast period from 2018 to 2032. North America led the market in 2018, accounting for a 29.08% share.

The ophthalmic lasers market is experiencing steady growth, driven by the increasing prevalence of eye disorders such as cataracts, glaucoma, and diabetic retinopathy. As demand for minimally invasive and precise eye treatments rises, advanced laser technologies are being rapidly adopted across eye care centers and surgical facilities. The market is segmented by product type, application, and end users, with each category offering unique growth opportunities. While high equipment costs and regulatory challenges may restrain expansion, the growing elderly population and rising awareness about vision health continue to fuel market momentum. With strong demand across both developed and emerging regions, the ophthalmic lasers market is set to play a vital role in the future of ophthalmic care.

Continue reading for more details:

**https://www.fortunebusinessinsights.com/industry-reports/ophthalmic-lasers-market-100952**

Market Segmentation

• By Product Type: Includes femtosecond lasers, excimer lasers, diode lasers, and YAG lasers.
• By Application: Covers cataract removal, refractive error correction, glaucoma treatment, and diabetic eye disease management.
• By End User: Segmented into hospitals, ambulatory surgical centers, and ophthalmic clinics.

List of Companies Profiled:

• IRIDEX Corporations
• Lumenis
• NIDEK CO., LTD.
• Carl Ziess Meditec AG
• Ellex Medical Lasers Ltd.
• TOPCON CORPORATION
• NoIR Laser Company, LLC
• Lumibird
• Other players